<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4-a.5'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/pulmonary-arterial-hypertension-pah-in-the-era-of-obesity-navigating-phenotypes-of-pulmonary-hypertension-expert-review-of-respiratory-medicine-october-22-2026/</loc>
  <lastmod>2026-10-27T21:39:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Pulmonary arterial hypertension (PAH) in the era of obesity: navigating phenotypes of pulmonary hypertension, Expert Review of Respiratory Medicine, October 22, 2026</news:title>
   <news:publication_date>2026-10-27T21:38:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/first-report-of-real-world-utilization-of-an-activin-signaling-inhibitor-in-patients-with-severe-pulmonary-arterial-hypertension-in-the-middle-east-pulmonary-circulation-ph-riseoctober-22-2026/</loc>
  <lastmod>2026-10-27T21:31:16Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East, Pulmonary Circulation, October 22, 2026</news:title>
   <news:publication_date>2026-10-27T21:30:54Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
